Details of the Drug | DrugMAP

General Information of Drug (ID: DMQOGY8)

Drug Name

Recombinant novel coronavirus vaccine

Synonyms

Adenovirus type 5 vector

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

TTD ID: D0I5ZX

References

1	ClinicalTrials.gov (NCT04341389) A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector). U.S. National Institutes of Health.